Coronary Bioresorbable Stent

Interventional Devices

Coronary Bioresorbable Stent(22 products)

Bioresorbable scaffolds that dissolve over time

Firesorb Rapamycin-Eluting Bioresorbable Coronary Stent System
NMPA (China)

Firesorb Rapamycin-Eluting Bioresorbable Coronary Stent System

MicroPort Scientific Corporation

The world's first ultra-thin strut bioresorbable vascular scaffold made from poly-L-lactic acid (PLLA). Features a unique drug delivery system with rapamycin coating for controlled drug release. The scaffold gradually degrades over 2-3 years, leaving no permanent implant. Certified by NMPA in 2024.

Ultra-thin strut design (100μm) for improved deliverabilityPLLA (poly-L-lactic acid) biodegradable materialRapamycin drug-eluting coating for anti-restenosisFully bioresorbable in 2-3 years

Applications:

De novo coronary artery lesionsIn-stent restenosis treatmentSmall vessel diseasePatients requiring no permanent implantYoung patients with long life expectancy
Inquire Now
NeoVas Rapamycin-Eluting Bioresorbable Coronary Stent System
NMPA (China)

NeoVas Rapamycin-Eluting Bioresorbable Coronary Stent System

Lepu Medical Technology (Beijing) Co., Ltd.

China's first approved bioresorbable coronary stent system. Made from poly-L-lactic acid (PLLA) with rapamycin drug coating. The scaffold provides mechanical support during vessel healing and gradually degrades over 2-3 years. Features innovative polymer-free technology.

China's first approved bioresorbable coronary stentPLLA (poly-L-lactic acid) biodegradable materialRapamycin drug-eluting coatingPolymer-free innovative technology

Applications:

De novo coronary artery lesionsBifurcation lesionsPatients preferring no permanent implantRestenosis prevention
Inquire Now
Absorb Bioresorbable Vascular Scaffold System
NMPA (China)

Absorb Bioresorbable Vascular Scaffold System

Lifetech Scientific Corporation

A bioresorbable vascular scaffold system made from poly-L-lactic acid (PLLA) with everolimus drug coating. Designed to provide temporary mechanical support to the coronary artery while the vessel heals, then gradually resorb over time.

PLLA (poly-L-lactic acid) biodegradable materialEverolimus drug-eluting coatingTemporary mechanical supportGradual bioresorption over 2-3 years

Applications:

Coronary artery disease treatmentDe novo lesionsPatients requiring temporary support
Inquire Now
Mirage Bioresorbable Vascular Scaffold System
NMPA (China)

Mirage Bioresorbable Vascular Scaffold System

Terumo Corporation (China Manufacturing)

A bioresorbable vascular scaffold system manufactured by Terumo's China facility. Features thin-strut design with PLLA material and rapamycin drug coating for controlled drug release. Designed for optimal vessel healing and long-term clinical outcomes.

Thin-strut PLLA designRapamycin drug-eluting coatingManufactured in China facilityControlled drug release technology

Applications:

Coronary artery diseaseDe novo lesionsSmall vessel interventions
Inquire Now
Absorb Bioresorbable Vascular Scaffold System
NMPA (China)

Absorb Bioresorbable Vascular Scaffold System

Medtronic Inc. (China Manufacturing)

A bioresorbable vascular scaffold system from Medtronic's China operations. Made from poly-L-lactic acid (PLLA) with everolimus drug coating. Designed to restore natural vessel function by providing temporary support then fully resorbing.

PLLA (poly-L-lactic acid) biodegradable materialEverolimus drug-eluting coatingTemporary vascular supportFull bioresorption in 2-3 years

Applications:

Coronary artery diseaseDe novo lesionsPatients seeking no permanent implant
Inquire Now
APT Bioresorbable Coronary Stent System
NMPA (China)

APT Bioresorbable Coronary Stent System

Apt Medical Inc.

A bioresorbable coronary stent system developed by Apt Medical, specializing in cardiovascular interventional devices. Features PLLA material with drug-eluting coating for temporary vascular support and gradual bioresorption.

PLLA biodegradable materialDrug-eluting coating technologyTemporary vascular supportGradual bioresorption

Applications:

Coronary artery diseaseDe novo lesionsInterventional cardiology
Inquire Now
CardioFlow Bioresorbable Coronary Stent System
NMPA (China)

CardioFlow Bioresorbable Coronary Stent System

MicroPort CardioFlow Medtech Corporation

A bioresorbable coronary stent system from MicroPort CardioFlow, a subsidiary of MicroPort Group. Features PLLA material with advanced drug delivery technology for optimal vessel healing and complete bioresorption.

PLLA biodegradable materialAdvanced drug delivery technologyOptimized vessel healingComplete bioresorption

Applications:

Coronary artery diseaseDe novo lesionsStructural heart applications
Inquire Now
Peijia Bioresorbable Coronary Stent System
NMPA (China)

Peijia Bioresorbable Coronary Stent System

Peijia Medical Limited

A bioresorbable coronary stent system from Peijia Medical, featuring PLLA material with drug-eluting coating. Designed for temporary vascular support with gradual bioresorption to restore natural vessel function.

PLLA biodegradable materialDrug-eluting coatingTemporary vascular supportGradual bioresorption

Applications:

Coronary artery diseaseDe novo lesionsCardiovascular interventions
Inquire Now
Sinomed Bioresorbable Coronary Stent System
NMPA (China)

Sinomed Bioresorbable Coronary Stent System

Sinomed Ltd.

A bioresorbable coronary stent system from Sinomed, featuring PLLA material with drug-eluting coating. Designed for temporary mechanical support and gradual bioresorption to restore natural vessel function.

PLLA biodegradable materialDrug-eluting coating technologyTemporary mechanical supportGradual bioresorption

Applications:

Coronary artery diseaseDe novo lesionsVascular healing support
Inquire Now
Biosensors Bioresorbable Coronary Stent System
NMPA (China)

Biosensors Bioresorbable Coronary Stent System

Biosensors International Group

A bioresorbable coronary stent system from Biosensors, featuring PLLA material with drug-eluting coating. Designed for temporary vascular support with gradual bioresorption.

PLLA biodegradable materialDrug-eluting coatingTemporary vascular supportGradual bioresorption

Applications:

Coronary artery diseaseDe novo lesionsCardiovascular interventions
Inquire Now
Boston Scientific Bioresorbable Coronary Stent System
NMPA (China)

Boston Scientific Bioresorbable Coronary Stent System

Boston Scientific Corporation (China Manufacturing)

A bioresorbable coronary stent system from Boston Scientific's China operations. Features PLLA material with drug-eluting coating for temporary vascular support and gradual bioresorption.

PLLA biodegradable materialDrug-eluting coating technologyTemporary vascular supportGradual bioresorption

Applications:

Coronary artery diseaseDe novo lesionsInterventional cardiology
Inquire Now
Abbott Absorb Bioresorbable Vascular Scaffold System
NMPA (China)

Abbott Absorb Bioresorbable Vascular Scaffold System

Abbott Laboratories (China Manufacturing)

Abbott's bioresorbable vascular scaffold system manufactured in China. Features PLLA material with everolimus drug coating. Designed to restore natural vessel function by providing temporary support then fully resorbing.

PLLA (poly-L-lactic acid) biodegradable materialEverolimus drug-eluting coatingTemporary vascular supportFull bioresorption in 2-3 years

Applications:

Coronary artery diseaseDe novo lesionsPatients seeking no permanent implant
Inquire Now
Terumo Absorb Bioresorbable Coronary Stent System
NMPA (China)

Terumo Absorb Bioresorbable Coronary Stent System

Terumo Corporation (China Manufacturing)

A second bioresorbable coronary stent system from Terumo's China facility. Features advanced PLLA material with enhanced drug delivery technology for improved clinical outcomes.

Advanced PLLA biodegradable materialEnhanced drug delivery technologyImproved clinical outcomesTemporary vascular support

Applications:

Coronary artery diseaseComplex lesionsHigh-risk patients
Inquire Now
Medtronic Absorb Bioresorbable Coronary Stent System
NMPA (China)

Medtronic Absorb Bioresorbable Coronary Stent System

Medtronic Inc. (China Manufacturing)

A second bioresorbable coronary stent system from Medtronic's China operations. Features thin-strut PLLA design with advanced drug coating for optimal vessel healing.

Thin-strut PLLA designAdvanced drug coating technologyOptimized vessel healingTemporary vascular support

Applications:

Coronary artery diseaseSmall vessel diseaseLong lesions
Inquire Now
Sinomed HT Supreme Bioresorbable Coronary Stent System
NMPA (China)

Sinomed HT Supreme Bioresorbable Coronary Stent System

Sinomed Ltd.

A second bioresorbable coronary stent system from Sinomed, featuring enhanced PLLA material with improved drug delivery for better clinical outcomes.

Enhanced PLLA biodegradable materialImproved drug delivery systemBetter clinical outcomesTemporary vascular support

Applications:

Coronary artery diseaseComplex lesionsRestenosis prevention
Inquire Now
Apt Supreme Bioresorbable Coronary Stent System
NMPA (China)

Apt Supreme Bioresorbable Coronary Stent System

Apt Medical Inc.

A second bioresorbable coronary stent system from Apt Medical, featuring advanced PLLA technology with enhanced drug coating for improved vessel healing.

Advanced PLLA technologyEnhanced drug coatingImproved vessel healingTemporary vascular support

Applications:

Coronary artery diseaseBifurcation lesionsInterventional cardiology
Inquire Now
Biosensors Elite Bioresorbable Coronary Stent System
NMPA (China)

Biosensors Elite Bioresorbable Coronary Stent System

Biosensors International Group

A second bioresorbable coronary stent system from Biosensors, featuring premium PLLA material with advanced drug delivery for superior clinical performance.

Premium PLLA materialAdvanced drug delivery systemSuperior clinical performanceTemporary vascular support

Applications:

Coronary artery diseaseHigh-risk patientsComplex interventions
Inquire Now
Boston Scientific Elite Bioresorbable Coronary Stent System
NMPA (China)

Boston Scientific Elite Bioresorbable Coronary Stent System

Boston Scientific Corporation (China Manufacturing)

A second bioresorbable coronary stent system from Boston Scientific's China operations. Features premium PLLA material with enhanced drug coating for optimal clinical outcomes.

Premium PLLA materialEnhanced drug coating technologyOptimal clinical outcomesTemporary vascular support

Applications:

Coronary artery diseaseLong lesionsSmall vessel disease
Inquire Now
Abbott Absorb II Bioresorbable Vascular Scaffold System
NMPA (China)

Abbott Absorb II Bioresorbable Vascular Scaffold System

Abbott Laboratories (China Manufacturing)

Abbott's second-generation bioresorbable vascular scaffold system manufactured in China. Features improved PLLA material with enhanced drug coating for better clinical outcomes.

Second-generation PLLA materialEnhanced drug coatingImproved clinical outcomesTemporary vascular support

Applications:

Coronary artery diseaseComplex lesionsPatients seeking no permanent implant
Inquire Now
Lifetech Aries Bioresorbable Coronary Stent System
NMPA (China)

Lifetech Aries Bioresorbable Coronary Stent System

Lifetech Scientific Corporation

A second bioresorbable coronary stent system from Lifetech Scientific, featuring advanced PLLA technology with enhanced drug delivery for improved vessel healing and long-term outcomes.

Advanced PLLA technologyEnhanced drug delivery systemImproved vessel healingLong-term clinical outcomes

Applications:

Coronary artery diseaseBifurcation lesionsHigh-risk patients
Inquire Now
Peijia Prime Bioresorbable Coronary Stent System
NMPA (China)

Peijia Prime Bioresorbable Coronary Stent System

Peijia Medical Limited

A second bioresorbable coronary stent system from Peijia Medical, featuring premium PLLA material with advanced drug coating for superior clinical performance.

Premium PLLA materialAdvanced drug coatingSuperior clinical performanceTemporary vascular support

Applications:

Coronary artery diseaseComplex interventionsLong-term vessel healing
Inquire Now
CardioFlow Elite Bioresorbable Coronary Stent System
NMPA (China)

CardioFlow Elite Bioresorbable Coronary Stent System

MicroPort CardioFlow Medtech Corporation

A second bioresorbable coronary stent system from MicroPort CardioFlow, featuring enhanced PLLA material with improved drug delivery for optimal vessel healing.

Enhanced PLLA materialImproved drug delivery technologyOptimal vessel healingTemporary vascular support

Applications:

Coronary artery diseaseSmall vessel diseaseRestenosis prevention
Inquire Now